Joseph A Ladapo1, Chi-Hong Tseng2, Scott E Sherman3. 1. Division of General Internal Medicine and Health Services Research, David Geffen School of Medicine at University of California, Los Angeles; Department of Population Health, New York University School of Medicine, New York. Electronic address: jladapo@mednet.ucla.edu. 2. Division of General Internal Medicine and Health Services Research, David Geffen School of Medicine at University of California, Los Angeles. 3. Department of Population Health, New York University School of Medicine, New York; Department of Medicine, VA New York Harbor Healthcare System, New York; Department of Medicine, New York University School of Medicine, New York.
Abstract
BACKGROUND: Financial incentives for smoking cessation and use of evidence-based therapy may increase quitting rates and reduce health and economic disparities. METHODS: We randomized a low-income population of 182 hospitalized patients (mean age 58 years, 45% with high school education or less) to enhanced usual care, which included hospital-directed cessation care and Quitline referral or enhanced usual care plus financial incentives. All patients received enhanced usual care, while participants randomized to the financial incentives group were also eligible to receive up to $550 for participation in Quitline counseling ($50), participation in a community-based cessation program ($50), use of pharmacotherapy ($50), and biochemically confirmed smoking cessation at 2 months ($150) and 6 months ($250). Primary outcome was biochemically confirmed smoking cessation at 6 months after hospital discharge. RESULTS:Total mean payment was $84 (standard deviation [SD] = $133) in the incentive group. The 6-month rate of biochemically confirmed smoking cessation was 19.6% in the incentive group and 8.9% in the enhanced usual care group (odds ratio [OR] 2.56; 95% confidence interval [CI] 0.84 to 7.83, P = 0.10). Participants in the incentive group had higher rates of nicotine replacement therapy use (57.3% vs 31.3%, P = 0.002). Financial incentives did not improve subjective social status but did increase financial stress. CONCLUSIONS:Rates of bioconfirmed smoking cessation were higher among hospitalized patients randomized to financial incentives compared to usual care alone, but the difference was not significant. Considering the frequency of low payouts and the importance of assistance for successful quitting, future studies should explore the effectiveness of financial incentives sufficiently large to overcome barriers to evidence-based therapy.
RCT Entities:
BACKGROUND: Financial incentives for smoking cessation and use of evidence-based therapy may increase quitting rates and reduce health and economic disparities. METHODS: We randomized a low-income population of 182 hospitalized patients (mean age 58 years, 45% with high school education or less) to enhanced usual care, which included hospital-directed cessation care and Quitline referral or enhanced usual care plus financial incentives. All patients received enhanced usual care, while participants randomized to the financial incentives group were also eligible to receive up to $550 for participation in Quitline counseling ($50), participation in a community-based cessation program ($50), use of pharmacotherapy ($50), and biochemically confirmed smoking cessation at 2 months ($150) and 6 months ($250). Primary outcome was biochemically confirmed smoking cessation at 6 months after hospital discharge. RESULTS: Total mean payment was $84 (standard deviation [SD] = $133) in the incentive group. The 6-month rate of biochemically confirmed smoking cessation was 19.6% in the incentive group and 8.9% in the enhanced usual care group (odds ratio [OR] 2.56; 95% confidence interval [CI] 0.84 to 7.83, P = 0.10). Participants in the incentive group had higher rates of nicotine replacement therapy use (57.3% vs 31.3%, P = 0.002). Financial incentives did not improve subjective social status but did increase financial stress. CONCLUSIONS: Rates of bioconfirmed smoking cessation were higher among hospitalized patients randomized to financial incentives compared to usual care alone, but the difference was not significant. Considering the frequency of low payouts and the importance of assistance for successful quitting, future studies should explore the effectiveness of financial incentives sufficiently large to overcome barriers to evidence-based therapy.
Authors: Alfredo J Selim; William Rogers; John A Fleishman; Shirley X Qian; Benjamin G Fincke; James A Rothendler; Lewis E Kazis Journal: Qual Life Res Date: 2008-12-03 Impact factor: 4.147
Authors: Karine Suissa; Jordan Larivière; Mark J Eisenberg; Maria Eberg; Genevieve C Gore; Roland Grad; Lawrence Joseph; Pauline M Reynier; Kristian B Filion Journal: Circ Cardiovasc Qual Outcomes Date: 2017-01
Authors: Joanna M Streck; Yuchiao Chang; Hilary A Tindle; Susan Regan; Elyse R Park; Douglas E Levy; Daniel E Singer; Thomas Ylioja; Nancy A Rigotti Journal: J Hosp Med Date: 2018-08-29 Impact factor: 2.960
Authors: John R Hughes; Josue P Keely; Ray S Niaura; Deborah J Ossip-Klein; Robyn L Richmond; Gary E Swan Journal: Nicotine Tob Res Date: 2003-02 Impact factor: 4.244
Authors: David H Au; Christopher L Bryson; Jason W Chien; Haili Sun; Edmunds M Udris; Laura E Evans; Katharine A Bradley Journal: J Gen Intern Med Date: 2009-02-05 Impact factor: 5.128
Authors: Stefanie E Schöttl; Martin Niedermeier; Prisca Kopp-Wilfling; Anika Frühauf; Carina S Bichler; Monika Edlinger; Bernhard Holzner; Martin Kopp Journal: BMC Sports Sci Med Rehabil Date: 2022-06-21
Authors: Dana Alkhoury; Jared Atchison; Antonio J Trujillo; Kimberly Oslin; Katherine P Frey; Robert V O'Toole; Renan C Castillo; Nathan N O'Hara Journal: Health Econ Rev Date: 2021-04-26
Authors: Xue Weng; Yongda Wu; Tzu Tsun Luk; William Ho Cheung Li; Derek Yee Tak Cheung; Henry Sau Chai Tong; Vienna Lai; Tai Hing Lam; Man Ping Wang Journal: Lancet Reg Health West Pac Date: 2021-07-05
Authors: Charlotta Pisinger; Cecilie Goltermann Toxværd; Mette Rasmussen Journal: Int J Environ Res Public Health Date: 2022-08-31 Impact factor: 4.614